1Spatial Plc (AIM:SPA)

Verve Therapeutics Cash Flow Statement

Financials in millions GBP. Fiscal year is February - January.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Net Income	0.17	1.18	1.06	0.38	-1.13
Depreciation & Amortization	1.35	1.15	1.49	1.39	1.78
Other Amortization	2.84	2.26	1.87	2.05	2.33
Stock-Based Compensation	0.01	-0.03	0.19	0.33	0.27
Other Operating Activities	-0.09	-0.06	0.17	0.08	0.15
Change in Accounts Receivable	-1.66	1.2	-1.43	-1.78	-0.66
Change in Accounts Payable	1.54	-1.31	1.96	0.21	1.45
Change in Other Net Operating Assets	-0.02	0.01	0.01	-0.11	0.09
Operating Cash Flow	4.14	4.38	5.32	2.54	4.29
Operating Cash Flow Growth	-5.47%	-17.61%	109.57%	-40.79%	478.68%
Capital Expenditures	-0.22	-0.07	-0.16	-0.16	-0.19
Sale (Purchase) of Intangibles	-4.84	-5.3	-3.85	-2.45	-2.12
Other Investing Activities	-0.46	-	-	-	-
Investing Cash Flow	-5.52	-5.36	-4.02	-2.61	-2.31
Long-Term Debt Issued	2.12	1.9	0.5	-	1.8
Long-Term Debt Repaid	-1.48	-1.54	-2.14	-1.51	-1.22
Total Debt Repaid	-1.48	-1.54	-2.14	-1.51	-1.22
Net Debt Issued (Repaid)	0.64	0.36	-1.64	-1.51	0.59
Issuance of Common Stock	0.13	0.02	0.01	-	-
Other Financing Activities	-	-	-0.35	-	-0.59
Financing Cash Flow	0.77	0.38	-1.98	-1.51	-
Foreign Exchange Rate Adjustments	-0.03	-0.17	0.09	-0.07	0.19
Net Cash Flow	-0.63	-0.78	-0.59	-1.66	2.17
Free Cash Flow	3.93	4.32	5.16	2.38	4.1
Free Cash Flow Growth	-9.01%	-16.30%	117.18%	-42.02%	572.58%
Free Cash Flow Margin	11.77%	13.36%	17.19%	8.79%	16.65%
Free Cash Flow Per Share	0.03	0.04	0.04	0.02	0.04
Cash Interest Paid	0.68	0.41	0.23	0.15	0.22
Cash Income Tax Paid	0.22	-0.14	-0.18	-0.18	-0.48
Levered Free Cash Flow	-0.63	-1.19	0.74	0.17	1.46
Unlevered Free Cash Flow	-0.27	-1	0.84	0.27	1.56
Change in Net Working Capital	0.28	0.31	-0.41	1.14	-0.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.